Fund Holdings — Redmile Group, LLC

Total Portfolio Value:
$1.06B
Total Bought:
$56.18M
Total Sold:
$350.30M
Net Transaction:
-$294.12M
Notable People:
Jeremy Charles Green, Joshua Damian Garcia, Bryan Ranney Crapo, Michael Stewart Lee, Robert Carrington Faulkner, Travis John Breznak
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Scholar Rock Holding Corporation(SRRK)4,549,8814,398,281-151,600$196.65M$141.40M13.37%-$55.24M
Krystal Biotech, Inc.(KRYS)753,175737,675-15,500$117.99M$133.00M12.57%+$15.01M
Amicus Therapeutics Inc
COM
7,054,8909,533,669+2,478,779$66.46M$77.79M7.35%+$11.34M
Zymeworks Inc.(ZYME)4,840,4634,788,945-51,518$70.86M$57.04M5.39%-$13.83M
Nurix Therapeutics, Inc.(NRIX)4,192,6274,051,927-140,700$78.99M$48.14M4.55%-$30.85M
Replimune Group, Inc.(REPL)4,905,5274,898,527-7,000$59.41M$47.76M4.51%-$11.65M
LivaNova PLCSHS(LIVN)1,043,5391,014,139-29,400$48.33M$39.84M3.77%-$8.49M
Akero Therapeutics Inc1,235,209939,277-295,932$34.36M$38.02M3.59%+$3.66M
Immunome, Inc.(IMNM)4,828,0265,361,187+533,161$51.27M$36.08M3.41%-$15.19M
REGENXBIO Inc.(RGNX)4,794,7804,794,7800$37.06M$34.28M3.24%-$2.78M
Beam Therapeutics Inc.(BEAM)1,528,5671,610,329+81,762$37.91M$31.45M2.97%-$6.46M
Stoke Therapeutics, Inc.(STOK)4,593,6294,485,981-107,648$50.67M$29.83M2.82%-$20.84M
Kymera Therapeutics, Inc.(KYMR)1,100,432983,413-117,019$44.27M$26.92M2.54%-$17.35M
ADC Therapeutics SASHS(ADCT)15,666,73115,666,7310$31.18M$22.09M2.09%-$9.09M
Biohaven Ltd.(BHVN)904,496867,454-37,042$33.78M$20.85M1.97%-$12.93M
Absci Corporation8,253,3168,253,3160$21.62M$20.72M1.96%-$907.9K
Boston Scientific Corporation(BSX)312,683193,283-119,400$27.93M$19.50M1.84%-$8.43M
Cogent Biosciences, Inc.(COGT)3,554,8363,216,026-338,810$27.73M$19.26M1.82%-$8.46M
Neurogene Inc.(NGNE)1,319,7631,308,063-11,700$30.17M$15.32M1.45%-$14.85M
89bio Inc2,167,1761,886,444-280,732$16.95M$13.71M1.30%-$3.23M
Establishment Labs Holdings Inc.(ESTA)320,149335,366+15,217$14.75M$13.68M1.29%-$1.06M
Annexon, Inc.(ANNX)6,300,6446,300,6440$32.32M$12.16M1.15%-$20.16M
Celldex Therapeutics, Inc.(CLDX)615,775590,175-25,600$15.56M$10.71M1.01%-$4.85M
Fate Therapeutics, Inc.(FATE)12,872,94612,872,9460$21.24M$10.17M0.96%-$11.07M
IDEAYA Biosciences, Inc.(IDYA)619,300534,600-84,700$15.92M$8.76M0.83%-$7.16M
Immunovant, Inc.(IMVT)571,824490,394-81,430$14.16M$8.38M0.79%-$5.78M
CeriBell, Inc.(CBLL)435,239435,2390$11.26M$8.36M0.79%-$2.90M
Rapt Therapeutics Inc6,475,3176,475,3170$10.23M$7.90M0.75%-$2.33M
Solid Biosciences Inc615,2462,019,171+1,403,925$2.46M$7.47M0.71%+$5.01M
Insulet Corporation(PODD)9,55927,109+17,550$2.50M$7.12M0.67%+$4.62M
BioNTech SEADS(BNTX)83,47173,071-10,400$9.51M$6.65M0.63%-$2.86M
Silence Therapeutics plcADS(SLN)2,399,3172,214,947-184,370$16.51M$6.25M0.59%-$10.26M
Penumbra, Inc.(PEN)25,74322,843-2,900$6.11M$6.11M0.58%-$5.0K
iRhythm Holdings, Inc.(IRTC)056,844+56,844$0$5.95M0.56%+$5.95M
Keros Therapeutics, Inc.(KROS)552,506552,5060$8.75M$5.63M0.53%-$3.12M
Verve Therapeutics Inc1,318,1641,207,164-111,000$7.43M$5.52M0.52%-$1.92M
Nuvation Bio Inc.CL A(NUVB)3,031,0093,031,0090$8.06M$5.33M0.50%-$2.73M
Shattuck Labs, Inc.(STTK)5,539,7245,539,7240$6.70M$5.26M0.50%-$1.44M
Masimo Corp026,062+26,062$0$4.34M0.41%+$4.34M
Prime Medicine, Inc.(PRME)2,074,3502,074,3500$6.06M$4.13M0.39%-$1.93M
Oruka Therapeutics, Inc.(ORKA)411,728386,963-24,765$7.98M$3.97M0.38%-$4.01M
Igm Biosciences Inc2,952,1312,952,1310$18.04M$3.39M0.32%-$14.64M
Cytokinetics, Incorporated(CYTK)92,59882,098-10,500$4.36M$3.30M0.31%-$1.06M
4d Molecular Therapeutics In1,196,910997,235-199,675$6.67M$3.22M0.30%-$3.45M
Pliant Therapeutics, Inc.(PLRX)2,895,4782,053,559-841,919$38.13M$2.77M0.26%-$35.36M
Lava Therapeutics NvSHS2,074,3722,074,3720$1.97M$2.63M0.25%+$661.7K
Atara Biotherapeutics Inc441,701441,7010$5.88M$2.62M0.25%-$3.26M
Xeris Biopharma Holdings Inc451,099451,0990$1.53M$2.48M0.23%+$947.3K
ALX Oncology Holdings Inc.(ALXO)3,689,6113,640,834-48,777$6.16M$2.27M0.21%-$3.89M
Repare Therapeutics Inc1,916,0891,884,389-31,700$2.51M$1.86M0.18%-$652.3K
Ventyx Biosciences Inc124,1781,569,793+1,445,615$271.9K$1.81M0.17%+$1.53M
Astria Therapeutics Inc346,278269,078-77,200$3.10M$1.44M0.14%-$1.66M
Invivyd, Inc.(IVVD)3,012,2542,285,320-726,934$1.33M$1.38M0.13%+$48.6K
Boundless Bio, Inc.(BOLD)740,204725,204-15,000$2.15M$1.10M0.10%-$1.05M
Kalaris Therapeutics, Inc.(KLRS)082,955+82,955$0$666.1K0.06%+$666.1K
Allakos Inc3,015,097856,615-2,158,482$3.65M$195.0K0.02%-$3.45M
AC Immune SASHS(ACIU)1,034,2990-1,034,299$2.79M$0—-$2.79M
Achilles Therapeutics PlcADS1,608,0890-1,608,089$1.83M$0—-$1.83M
Adaptimmune Therapeutics plcADR(ADAPY)715,6070-715,607$385.5K$0—-$385.5K
Allovir Inc1,907,9690-1,907,969$801.3K$0—-$801.3K
Ardelyx Inc1,576,2590-1,576,259$7.99M$0—-$7.99M
Hookipa Pharma Inc106,3760-106,376$213.8K$0—-$213.8K
Intuitive Surgical, Inc.(ISRG)16,9430-16,943$8.84M$0—-$8.84M
Stereotaxis, Inc.(STXS)1,799,4650-1,799,465$4.10M$0—-$4.10M
Stryker Corporation(SYK)30,6760-30,676$11.04M$0—-$11.04M
Page 1 of 1
Redmile Group, LLC — 13F Holdings — Q1 2025 | TickerTrail